BLA761495 ()
New biologicPriority review
- Region
- 🇺🇸 US
- Company
- Merck Sharp And Dohme Llc
- Status
- Approved
- FDA approval
- Wed 15 Oct 2025
- Designations
- New biologic, Priority review
- Application
- BLA761495
- Official record
- www.accessdata.fda.gov
Regulatory milestones
Wed 15 Oct 2025🇺🇸 FDA approval
FDA approves BLA761495, a new medicine
Merck Sharp And Dohme Llc; BLA761495; New biologic, Priority review · source
Follow BLA761495
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.